Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samar Al-Emadi

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
ACR Open Rheumatology|July 23, 2022
Development of a Prediction Model for COVID-19 Acute Respiratory Distress Syndrome in Patients With Rheumatic Diseases: Results From the Global Rheumatology Alliance RegistryZara Izadi, Milena A Gianfrancesco, Alfredo Aguirre, et al.
Annals of the Rheumatic Diseases|February 17, 2022
Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology AllianceManuel Francisco Ugarte-Gil, Graciela S Alarcón, Zara Izadi, et al.
The Lancet. Rheumatology|November 15, 2021
Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort studySebastian E Sattui, Richard Conway, Michael S Putman, et al.
The Lancet. Rheumatology|August 1, 2022
Environmental and societal factors associated with COVID-19-related death in people with rheumatic disease: an observational studyZara Izadi, Milena A Gianfrancesco, Gabriela Schmajuk, et al.
JAMA Network Open|October 18, 2021
Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19Zara Izadi, Erica J Brenner, Satveer K Mahil, et al.
Annals of the Rheumatic Diseases|May 29, 2021
Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registryJeffrey A Sparks, Zachary S Wallace, Andrea M Seet, et al.
The Lancet. Rheumatology|January 22, 2024
Global comment on the use of hydroxychloroquine during the periconception period and pregnancy in women with autoimmune diseasesKaren Schreiber, Ian Giles, Nathalie Costedoat-Chalumeau, et al.
Nature Genetics|November 5, 2022
Multi-ancestry genome-wide association analyses identify novel genetic mechanisms in rheumatoid arthritisKazuyoshi Ishigaki, Saori Sakaue, Chikashi Terao, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
ACR Open Rheumatology|July 23, 2022
Development of a Prediction Model for COVID-19 Acute Respiratory Distress Syndrome in Patients With Rheumatic Diseases: Results From the Global Rheumatology Alliance RegistryZara Izadi, Milena A Gianfrancesco, Alfredo Aguirre, et al.
Annals of the Rheumatic Diseases|February 17, 2022
Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology AllianceManuel Francisco Ugarte-Gil, Graciela S Alarcón, Zara Izadi, et al.
The Lancet. Rheumatology|November 15, 2021
Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort studySebastian E Sattui, Richard Conway, Michael S Putman, et al.
The Lancet. Rheumatology|August 1, 2022
Environmental and societal factors associated with COVID-19-related death in people with rheumatic disease: an observational studyZara Izadi, Milena A Gianfrancesco, Gabriela Schmajuk, et al.
JAMA Network Open|October 18, 2021
Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19Zara Izadi, Erica J Brenner, Satveer K Mahil, et al.
Annals of the Rheumatic Diseases|May 29, 2021
Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registryJeffrey A Sparks, Zachary S Wallace, Andrea M Seet, et al.
The Lancet. Rheumatology|January 22, 2024
Global comment on the use of hydroxychloroquine during the periconception period and pregnancy in women with autoimmune diseasesKaren Schreiber, Ian Giles, Nathalie Costedoat-Chalumeau, et al.
Nature Genetics|November 5, 2022
Multi-ancestry genome-wide association analyses identify novel genetic mechanisms in rheumatoid arthritisKazuyoshi Ishigaki, Saori Sakaue, Chikashi Terao, et al.
Pageof 6